Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications
DOI 10.1038/ncomms12150

Cited by (1,003)

Items 901–1,000 of 1,003

  1. Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells
    Nicola Tumino, Piera Filomena Fiore, Andrea Pelosi, Lorenzo Moretta, Paola Vacca · 2022 · Seminars in Immunology
  2. Coordinated Regulation of Myeloid-Derived Suppressor Cells by Cytokines and Chemokines
    Ru Li, Mousumi Beto Mukherjee, Jun Lin · 2022 · Cancers
  3. Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche
    Jesse Kreger, Evanthia T. Roussos Torres, Adam L. MacLean · 2023 · Cancer Immunology Research
  4. Targeting the myeloid microenvironment in neuroblastoma
    Marjolein C. Stip, Loes Teeuwen, Miranda P. Dierselhuis, Jeanette H.W. Leusen, Daniëlle Krijgsman · 2023 · Journal of Experimental & Clinical Cancer Research
  5. Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells
    Oliver Goldmann, Eva Medina · 2024 · Frontiers in Immunology
  6. Recruitment of Neutrophils Mediated by Vγ2 γδ T Cells Deteriorates Liver Fibrosis Induced by Schistosoma japonicum Infection in C57BL/6 Mice
    Zheng Li, Yuan Hu, Yanjuan Wang, Xi-Bao Huang, Yuxin Xu, Yujuan Shen, Jianping Cao · 2017 · Infection and Immunity
  7. Nonresolving macrophage‐mediated inflammation in malignancy
    Peter J. Murray · 2017 · FEBS Journal
  8. A drug development perspective on targeting tumor‐associated myeloid cells
    Meher Majety, Valeria Runza, Christian H.K. Lehmann, Sabine Hoves, Carola Hermine Ries · 2017 · FEBS Journal
  9. Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells
    Michelle Rodriques Goulart, Sabina I. Hlavaty, Yu‐Mei Chang, Gerry A. Polton, Anneliese J. Stell, James A. Perry, Ying Wu, Eshita Sharma, John Broxholme, Avery C. Lee et al. · 2019 · Scientific Reports
  10. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma
    Jamileh Nabizadeh, Helga D. Manthey, Nadya Panagides, Frederik J. Steyn, John D. Lee, Xaria X. Li, Fazrena Nadia Md Akhir, Weiyu Chen, Glen M. Boyle, Stephen M. Taylor et al. · 2019 · The FASEB Journal
  11. Targeting CXCR1/2: The medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead
    Jinxin Che, Rui Song, Binhui Chen, Xiaowu Dong · 2019 · European Journal of Medicinal Chemistry
  12. Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression
    Zhiqi Xie, Tamami Ikegami, Yukio Ago, Naoki Okada, Masashi Tachibana · 2020 · OncoImmunology
  13. Monocytic MDSCs skew Th17 cells toward a pro-osteoclastogenic phenotype and potentiate bone erosion in rheumatoid arthritis
    Shixian Chen, Chunqing Guo, Ran Wang, Zhitao Feng, Zheng Liu, Lisheng Wu, Di Zhao, Songyuan Zheng, Feilong Chen, Dingding Zhang et al. · 2020 · Rheumatology
  14. Dual roles of myeloid‑derived suppressor cells induced by Toll‑like receptor signaling in cancer (Review)
    Hongyue Zhou, Mengyu Jiang, Hongyan Yuan, Weihua Ni, Guixiang Tai · 2020 · Oncology Letters
  15. Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer
    Colt A. Egelston, Weihua Guo, Susan Elaine Yost, Jin Sun Lee, David L. Rose, Christian Avalos, Jian Ye, Paul Henry Frankel, Daniel D. Schmolze, James Ross Waisman et al. · 2021 · Journal for ImmunoTherapy of Cancer
  16. Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges
    Xiaoqing Li, Yixue Li, Qinru Yu, Pengxu Qian, He Huang, Yu Lin · 2021 · Journal of Leukocyte Biology
  17. Identification of Novel Low-Density Neutrophil Markers Through Unbiased High-Dimensional Flow Cytometry Screening in Non-Small Cell Lung Cancer Patients
    Paulina Valadez-Cosmes, Kathrin Stefanie Maitz, Oliver Kindler, Sofia Raftopoulou, Melanie Kienzl, Ana Santiso, Zala Nikita Mihalič, Luka Brčić, Jörg Lindenmann, Melanie Fediuk et al. · 2021 · Frontiers in Immunology
  18. PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
    Mingyu Liu, Chong Wu, Shufeng Luo, Qiaomin Hua, Haitian Chen, Yulan Weng, Junyu Xu, Huiling Lin, Lu Wang, Jinheng Li et al. · 2022 · The Journal of Experimental Medicine
  19. Blocking LAIR1 signaling in immune cells inhibits tumor development
    Xie, Jingjing, Gui, Xun, Deng, Mi, Chen, Heyu, Chen, Yuanzhi, Liu, Xiaoye, Ku, Zhiqiang, Tan, Lingxiao, Huang, Ryan, He, Yubo et al. · 2022 · Frontiers in Immunology
  20. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders
    Antero Salminen, Kai Kaarniranta, Anu Kauppinen · 2018 · International Immunopharmacology
  21. SOCS3 Suppression Promoted the Recruitment of CD11b+Gr-1−F4/80−MHCII− Early-Stage Myeloid-Derived Suppressor Cells and Accelerated Interleukin-6-Related Tumor Invasion via Affecting Myeloid Differentiation in Breast Cancer
    Wenwen Zhang, Mengmeng Jiang, Jieying Chen, Rui Zhang, Yingnan Ye, Pengpeng Liu, Wenwen Yu, Jinpu Yu · 2018 · Frontiers in Immunology
  22. Gut microbiota promotes immune tolerance at the maternal-fetal interface
    Julia A. Brown, Mohammed Amir, Shui Yu, Daniel S.H. Wong, Jinghua Gu, Uthra Balaji, Christopher N. Parkhurst, Seunghee Hong, Lucy R. Hart, Hannah C. Carrow et al. · 2025 · Cell
  23. Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer
    Chiara Camisaschi, Viviana Vallacchi, Elisabetta Vergani, Marcella Tazzari, Simona Ferro, Alessandra Tuccitto, Olga Kuchuk, Eriomina Shahaj, Roberta Sulsenti, Chiara Castelli et al. · 2016 · Vaccines
  24. Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients
    Kilian Wistuba‐Hamprecht, Alexander Martens, Benjamin Weide, Karen Wei Weng Teng, Henning Zelba, Elena Guffart, Jinmiao Chen, Claus Garbe, Evan William Newell, Anis Larbi et al. · 2016 · The Journal of Immunology
  25. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice
    Zhen Bian, Lei Shi, Mahathi Venkataramani, Ahmed Mansour Abdelaal, Courtney D Culpepper, Koby Kidder, Hongwei Liang, Ke Zen, Yuan Liu · 2017 · European Journal of Immunology
  26. Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility
    Keith Lough Kirkwood, Lixia Zhang, Ramkumar Thiyagarajan, Kenneth Ladd Seldeen, Bruce Robert Troen · 2018 · Immunological Investigations
  27. Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy
    Magali Lecavalier‐Barsoum, Naz Chaudary, Kathy Chai-Zung Han, Melania Pintilie, Richard Peter Hill, Michael Milosevic · 2019 · British Journal of Cancer
  28. Oncolytic virotherapy: new weapon for breast cancer treatment
    Veronica Martini, Francesca D’Avanzo, Paola Maria Maggiora, Feba Mariam Varughese, Antonio Sica, Alessandra Gennari · 2020 · ecancermedicalscience
  29. Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
    Sara De Biasi, Domenico Lo Tartaro, Lara Gibellini, Annamaria Paolini, Andrew A. Quong, Carlene Petes, Génève Awong, Samuel Douglas, Dongxia Lin, Jordan Nieto et al. · 2021 · Nature Communications
  30. Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients
    Glenn F. van Wigcheren, Nienke de Haas, Tom A. Mulder, Sophie K. Horrevorts, Martine Bloemendal, Simone Hins-de Bree, Yumeng Mao, Rolf W. Kiessling, Carla M.L. van Herpen, Georgina Flórez‐Grau et al. · 2021 · OncoImmunology
  31. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions
    Izabela Siemińska, Kazimierz Węglarczyk, Marcin Surmiak, Dorota Kurowska-Baran, Marek Sanak, Maciej Siedlar, Jarek Baran · 2021 · Frontiers in Immunology
  32. Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes
    Shiqi Wang, Qian Tan, Yayi Hou, Huan Dou · 2021 · Frontiers in Pharmacology
  33. Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
    A. Pullikuth, Eric D. Routh, Kip D. Zimmerman, J. Chifman, J. Chou, M. Soike, G. Jin, Jing Su, Qian-Qian Song, M. Black et al. · 2021 · Frontiers in Oncology
  34. Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly
    A. Betsch, Omer Rutgeerts, S. Fevery, Ben Sprangers, G. E. G. Verhoef, Daan Dierickx, M. Beckers · 2018 · Blood Reviews
  35. Low-dose decitabine modulates myeloid-derived suppressor cell fitness via LKB1 in immune thrombocytopenia
    Xiaofei Ni, Lingjun Wang, Haoyi Wang, Tianshu Yu, Jie Xie, Guosheng Li, Yanfeng Liu, Hai Zhou, Miao Xu, Ming Hou et al. · 2022 · Blood
  36. Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
    Vaishali Bhardwaj, Stephen Maxted Ansell · 2023 · Frontiers in Cell and Developmental Biology
  37. The spleen-liver axis supports obesity-induced systemic and fatty liver inflammation via MDSC and NKT cell enrichment.
    Christina Brummer, K. Singer, Kathrin Renner, C. Bruss, Claus Hellerbrand, Christoph Dorn, Simone Reichelt-Wurm, W. Gronwald, T. Pukrop, Wolfgang Herr et al. · 2025 · Molecular and Cellular Endocrinology
  38. Rab7 GTPase controls lipid metabolic signaling in myeloid-derived suppressor cells
    Xinchun Ding, Wenjing Zhang, Ting Zhao, Cong Yan, Hong Du · 2017 · Oncotarget
  39. In Vivo Imaging of Pro- and Antitumoral Cellular Components of the Tumor Microenvironment
    Anne Helfen, Johannes Roth, Tony Ng, Michel Eisenblätter · 2017 · Journal of Nuclear Medicine
  40. Lnc-C/EBPβ Modulates Differentiation of MDSCs Through Downregulating IL4i1 With C/EBPβ LIP and WDR5
    Yunhuan Gao, Wencong Shang, Dan Zhang, Shiwu Zhang, Xipeng Zhang, Yuan Zhang, Rongcun Yang · 2019 · Frontiers in Immunology
  41. C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions
    Rachel V. Jimenez, Valeriya Kuznetsova, Ashley N. Connelly, Zdeněk Hel, Alexander J. Szalai · 2019 · Frontiers in Immunology
  42. Specific Commensal Bacterium Critically Regulates Gut Microbiota Osteoimmunomodulatory Actions During Normal Postpubertal Skeletal Growth and Maturation
    Jessica D. Hathaway‐Schrader, Nicole A. Poulides, Matthew D. Carson, Joy E. Kirkpatrick, Amy J. Warner, Brooks A. Swanson, Eliza V Taylor, Michael E. Chew, Sakamuri V. Reddy, Bei Liu et al. · 2020 · JBMR Plus
  43. Immunosuppressive role of CD11b+CD33+HLA‐DR− myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
    Shin Young Hyun, Eun Jung Na, Ji Eun Jang, Haerim Chung, Soo‐Jeong Kim, Jin Seok Kim, Jee Hyun Kong, Kwang Yong Shim, Jong In Lee, Yoo Hong Min et al. · 2020 · Cancer Medicine
  44. Inflammation and immunity in ovarian cancer
    Diego Salas‐Benito, Enric Vercher, Enrique Conde, Javier Glez‐Vaz, Ibón Tamayo, Sandra Hervás‐Stubbs · 2020 · European Journal of Cancer Supplements
  45. Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target Cells
    Jiaying Liu, Randall Toy, Casey E. Vantucci, Pallab Pradhan, Zijian Zhang, Katie M. Kuo, Kelsey P. Kubelick, Da Huo, Jianguo Wen, Jinhwan Kim et al. · 2021 · Nano Letters
  46. Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells
    Marcin Domagala, Chloé Laplagne, Edouard Leveque, Camille Laurent, Jean‐Jacques Fournié, Éric Espinosa, Mary Poupot · 2021 · Cancers
  47. Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma
    Mattia Garutti, Serena Bonin, Silvia Buriolla, Elisa Bertoli, Maria Antonietta Pizzichetta, Iris Zalaudek, Fabio Puglisi · 2021 · Cancers
  48. Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy
    Xiuman Zhou, Ling Jiao, Yuzhen Qian, Qingyu Dong, Yixuan Sun, Wei Zheng, Wenshan Zhao, Wenjie Zhai, Lu Qiu, Yahong Wu et al. · 2021 · Biomolecules
  49. Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
    Yanan Li, Hongdan He, Ribu Jihu, Junfu Zhou, Rui Zeng, Hengxiu Yan · 2021 · Frontiers in Cell and Developmental Biology
  50. Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma
    Yukino Oshima, Makoto Sano, Ichie Kajiwara, Yoshimi Ichimaru, Tomoaki Itaya, Tomoya Kuramochi, Emiko Hayashi, Jinsuk Kim, Osamu Kitajima, Yohei Masugi et al. · 2022 · British Journal of Anaesthesia
  51. Myeloid‑derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
    Takahiro Tomiyama, Shinji Itoh, Norifumi Iseda, Katuya Toshida, Akinari Morinaga, Kyohei Yugawa, Yukiko Kosai‐Fujimoto, Takahiro Tomino, Takeshi Kurihara, Yoshihiro Nagao et al. · 2022 · Oncology Letters
  52. Routine laboratory parameters, including complete blood count, predict COVID-19 in-hospital mortality in geriatric patients
    Fabiola Olivieri, Jacopo Sabbatinelli, Anna Rita Bonfigli, Riccardo Sarzani, Piero Giordano, Antonio Cherubini, Roberto Antonicelli, Yuri Rosati, Simona Del Prete, Mirko Di Rosa et al. · 2022 · Mechanisms of Ageing and Development
  53. Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression
    Iosif Papafragkos, Maria Grigoriou, Louis Boon, Andreas Kloetgen, Aikaterini Hatzioannou, Panayotis Verginis · 2022 · Frontiers in Immunology
  54. The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
    María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Gabriel Cabrera, Elba Mónica Vermeulen, Luis de la Cruz‐Merino, Víctor Sánchez‐Margalet · 2022 · Frontiers in Immunology
  55. L ow‐dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo
    Francesca Romana Stefani, Sofia Eberstål, Stefano Vergani, Trine Ahn Kristiansen, Johan Bengzon · 2018 · International Journal of Cancer
  56. Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
    Meliha Mehmeti, Caroline Bergenfelz, Anna-Maria Larsson, R. Carlsson, Kristian Riesbeck, Jonas Ahl, Helena Janols, Marlene Wullt, Anders C. A. Bredberg, Eva Källberg et al. · 2020 · Life Science Alliance
  57. Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment
    Feng Zhang, Keshu Hu, Wenfeng Liu, Bing Quan, Miao Li, Shenxin Lu, Rongxin Chen, Zhenggang Ren, Xin Hua Yin · 2022 · Cellular and Molecular Gastroenterology and Hepatology
  58. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment
    Eric Jou, Natasha Chaudhury, Fizza Nasim · 2024 · Exploration of Targeted Anti-tumor Therapy
  59. Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME)
    Mahvash Sadeghi, Sajad Dehnavi, Moosa Sharifat, Amir Mohammad Amiri, Ali Khodadadi · 2024 · Heliyon
  60. The mazy case of Notch and immunoregulatory cells
    Paola Grazioli, María Pía Felli, Isabella Screpanti, Antonio Francesco Campese · 2017 · Journal of Leukocyte Biology
  61. Structural characterization of a pectin-type polysaccharide from Curcuma kwangsiensis and its effects on reversing MDSC-mediated T cell suppression
    Cai-Xia Dong, Wensheng Zhang, Qili Sun, Yun-Jia Jiang, Zheng Fu, Ying Zhang, Juan Du, Yuanxia Sun, Ning Tao, Zhi Yao · 2018 · International Journal of Biological Macromolecules
  62. Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
    Karishma R. Rajani, Lucas P. Carlstrom, Ian F. Parney, Aaron J. Johnson, Arthur E. Warrington, Terry C. Burns · 2019 · Frontiers in Oncology
  63. Indoleamine 2,3‐dioxygenase and tryptophan 2,3‐dioxygenase expression in HPV infection, SILs, and cervical cancer
    Paloma Almeida Venancio, Márcia Edilaine Lopes Consolaro, Sophie Derchain, Enrique Boccardo, Luisa L. Villa, Silvya Stuchi Maria–Engler, Ana Čampa, Michelle Garcia Discacciati · 2019 · Cancer Cytopathology
  64. MDSCs in pregnancy: Critical players for a balanced immune system at the feto-maternal interface
    Moslem Ahmadi, Mobin Mohammadi, Mohammad Ali‐Hassanzadeh, Maryam Zare, Behrouz Gharesi‐Fard · 2019 · Cellular Immunology
  65. Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
    Philipp Metzger, Sabrina Viktoria Kirchleitner, Michael Kluge, Lars M. König, Christine Hörth, Carlotta A. Rambuscheck, Daniel Böhmer, Julia Ahlfeld, Sebastian Kobold, Caroline C. Friedel et al. · 2019 · Journal for ImmunoTherapy of Cancer
  66. Mesenchymal stromal cells induce distinct myeloid-derived suppressor cells in inflammation
    Hyun Ju Lee, Jung Hwa Ko, Hyeon Ji Kim, Hyun Jeong Jeong, Joo Youn Oh · 2020 · JCI Insight
  67. BATF2 prevents glioblastoma multiforme progression by inhibiting recruitment of myeloid-derived suppressor cells
    Xin Zhang, Yi Liu, Lei Dai, Gang Shi, Jie V. Deng, Qiang Luo, Qian Xie, Lin Cheng, Chunlei Li, Yi Lin et al. · 2021 · Oncogene
  68. Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
    Mark D. Badeaux, Annah S. Rolig, Giulia Agnello, Danlee Enzler, Melissa J. Kasiewicz, Leslie Priddy, Jason F. Wiggins, Alexander Muir, Mark R. Sullivan, Jessica Van Cleef et al. · 2021 · Cancer Immunology Research
  69. Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients
    Zhitao Wang, Rui Jiang, Qian Li, Huiping Wang, Qianshan Tao, Zhimin Zhai · 2021 · Journal of Clinical Medicine
  70. ITLN1 inhibits tumor neovascularization and myeloid derived suppressor cells accumulation in colorectal carcinoma
    Li Chen, Xiaohan Jin, Jie Luo, Jin‐Ling Duan, Muyan Cai, Jiewei Chen, Zihao Feng, Austin Meng Guo, Feng‐Wei Wang, Dan Xie · 2021 · Oncogene
  71. Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment
    May Wathone Oo, Hotaka Kawai, Kiyofumi Takabatake, Shuta Tomida, Takanori Eguchi, Kisho Ono, Qiusheng Shan, Toshiaki Ohara, Saori Yoshida, Haruka Omori et al. · 2021 · JCI Insight
  72. Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer
    Izabela Siemińska, Jarek Baran · 2022 · Frontiers in Oncology
  73. Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
    Matthew Ho, Alexander H. Xiao, Dongni Yi, Saurabh Zanwar, Giada Bianchi · 2022 · Current Oncology
  74. Heterogeneity of Cholangiocarcinoma Immune Biology
    Francesca Vita, Irene Olaizola, Francesco Amato, Colin J. Rae, Sergi Marco, Jesús M. Bañales, Chiara Braconi · 2023 · Cells
  75. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment
    Duocai Li, Weidong Xu, Yifan Emily Chang, Yu‐Tian Xiao, Yundong He, Shancheng Ren · 2023 · Acta Biochimica et Biophysica Sinica
  76. Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system
    Giulia Grizzi, Mario Caccese, Αναστάσιος Γκουντάκος, Luisa Carbognin, Giampaolo Tortora, Emilio Bria, Sara Pilotto · 2017 · Expert Review of Molecular Diagnostics
  77. Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis
    Maximilian Moeller, Vanessa Orth, Viktor Umansky, Svetlana Hetjens, Volker Braun, Christoph Reißfelder, Julia Hardt, Steffen Seyfried · 2024 · Frontiers in Immunology
  78. Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance
    Yumin Fu, Xinyu Guo, Linmao Sun, Tianming Cui, Chenghui Wu, Jiabei Wang, Yao Liu, Lianxin Liu · 2024 · eLife
  79. Myeloid‐Derived Suppressor Cells in Cancer: Mechanistic Insights and Targeted Therapeutic Innovations
    Tianying Hu, Jianxue Zhai, Zhanda Yang, Jiajia Peng, Chuxuan Wang, Xinyao Liu, Yawen Li, Jiaqi Yao, Fengxi Chen, Haixia Li et al. · 2025 · MedComm
  80. Differential Regulation of Myeloid-Derived Suppressor Cells by Candida Species
    Anurag Singh, Felipe Lelis, Stefanie Braig, Iris Schäfer, Dominik Hartl, Nikolaus Peter Rieber · 2016 · Frontiers in Microbiology
  81. S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4–ERK1/2 Signaling
    Qingcui Li, Chengliang Dai, Rui Xue, Peigang Wang, Lin Chen, Yijie Han, Ulrike Erben, Zhihai Qin · 2018 · Frontiers in Immunology
  82. The role of myeloid-derived suppressor cells in chronic infectious diseases and the current methodology available for their study
    Hernán F. Peñaloza, Diana Alvarez, Natalia Muñoz‐Durango, Bárbara M. Schultz, Pablo A. González, Alexis M. Kalergis, Susan M. Bueno · 2018 · Journal of Leukocyte Biology
  83. Neutrophils and Close Relatives in the Hypoxic Environment of the Tuberculous Granuloma: New Avenues for Host-Directed Therapies?
    Aude Rémot, Emilie Doz, Nathalie Winter · 2019 · Frontiers in Immunology
  84. Role of myeloid-derived suppressor cells in immune checkpoint inhibitor therapy in cancer
    Su-Myeong Park, Je‐In Youn · 2019 · Archives of Pharmacal Research
  85. Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
    Carla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, Arianna Palladini, Pier‐Luigi Lollini, Patrizia Nanni · 2019 · Cancers
  86. Functional crosstalk between T cells and monocytes in cancer and atherosclerosis
    Lindsey E. Padgett, Daniel J. Araujo, Catherine C. Hedrick, Claire E. Olingy · 2020 · Journal of Leukocyte Biology
  87. Application of Anti-Inflammatory Agents in Prostate Cancer
    Koji Hatano, Kazutoshi Fujita, Norio Nonomura · 2020 · Journal of Clinical Medicine
  88. Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
    Boris Duchemann, Jordi Remón, Marie Naigeon, Lydie Cassard, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Édouard Auclin, Aude Desnoyer, Benjamin Besse et al. · 2021 · Translational Lung Cancer Research
  89. Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study
    Christoffer Gebhardt, Sonja C. S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael R. Reinhard, Tim Holland‐Letz, Viktor Umansky, Jochen Sven Utikal · 2020 · Cellular Immunology
  90. A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non–Small Cell Lung Cancer
    Michael Rahman Shafique, Terrence Lee Fisher, Elizabeth E. Evans, John E. Leonard, Desa Rae E. Pastore, Crystal L. Mallow, Ernest Smith, Vikas A. Mishra, Andreas Schröder, Kevin M. Chin et al. · 2021 · Clinical Cancer Research
  91. Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy
    Cristina Belgiovine, Roberta Frapolli, Manuela Liguori, Elisabeth Digifico, Federico Colombo, Marina Meroni, Paola Allavena, Maurizio D’Incalci · 2021 · European Journal of Immunology
  92. Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
    Yijun Wang, Tongyue Zhang, Mengyu Sun, Xiaoyu Ji, Meng Xie, Wenjie Huang, Limin Xia · 2021 · Cancers
  93. The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research
    Galaxia M. Rodriguez, Kristianne J.C. Galpin, David P. Cook, Edward Yakubovich, Vincent Maranda, Elizabeth A. Macdonald, Juliette Wilson‐Sanchez, Anjali L. Thomas, Joanna E. Burdette, Barbara C. Vanderhyden · 2022 · Cancer Research Communications
  94. Candida tropicalis induces NLRP3 inflammasome activation via glycogen metabolism-dependent glycolysis and JAK-STAT1 signaling pathway in myeloid-derived suppressor cells to promote colorectal carcinogenesis
    Zhiyong Zhang, Ying Chen, Yuxin Yin, Yuxi Chen, Qianyu Chen, Ziqian Bing, Yaojun Zheng, Yayi Hou, Sunan Shen, Yitian Chen et al. · 2022 · International Immunopharmacology
  95. Myeloid-derived suppressor cell: A crucial player in autoimmune diseases
    Dandan Xu, Cheng Li, Yushan Xu, Mingyue Huang, Dawei Cui, Jue Xie · 2022 · Frontiers in Immunology
  96. Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis
    Young Hun Chung, Oscar Antonio Ortega-Rivera, Britney A. Volckaert, Eunkyeong Jung, Zhongchao Zhao, Nicole F. Steinmetz · 2023 · Proceedings of the National Academy of Sciences
  97. Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance
    Katarzyna Aneta Pankowska, Grażyna Ewa Będkowska, Joanna Chociej-Stypułkowska, Małgorzata Rusak, M Dąbrowska, Joanna Osada · 2023 · International Journal of Molecular Sciences
  98. Review of possible mechanisms of radiotherapy resistance in cervical cancer
    Hanqun Zhang, Xiaohu Wang, Yan Ma, Qiuning Zhang, Ruifeng Liu, Hongtao Luo, Zi Wang · 2023 · Frontiers in Oncology
  99. Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5‐lipoxygenase‐dependent arachidonic acid pathway
    Xingchen Li, Guidong Chen, Fanchen Wang, Xiaojing Guo, Rui Zhang, Pengpeng Liu, Li Dong, Wenwen Yu, Huan Wang, Hailong Wang et al. · 2023 · Clinical and Translational Medicine
  100. Current state of immune checkpoints therapy for glioblastoma
    He Wang, Jing Yang, Xiangjun Li, Zhao Hai · 2024 · Heliyon